>> WE ARE HERE IN STANISLAUS COUNTY AT THE MODESTO MISSION CLINIC. WE ARE GOING TO WALK THROUGH THE CLINIC AS IF YOU ARE THE PATIENT. >> THIS IS A LOOK AT HOW MONOCLONAL THERAPY WORKS IT IS A PROMISING PREVENTATIVE MEASURE THAT COULD REDUCE SERIOUS, LOCATIONS DUE TO THE VIRUS. >> IT IS THE RIGHT THING TO DO. WE WOULD LIKE TO MAKE OUR COMMUNITY A HEALTHIER COMMUNITY. >> GOLDEN VALLEY HEALTH CENTERS IS THE ONLY OUTPATIENT CLINIC THAT OFFERS THIS TREATMENT. >> UNDERUTILIZED MEDICATION. >> WE HAVE A LIST OF — >> THREE WHERE THE LAST TO RECEIVE THE INFUSION. >> HE SAID HE CAN BREATHE BETTER. HE WANTED TO GO OUT. >> SHE SAYS THERE ARE SOME REQUIREMENTS FOR THEIR CLINIC. PATIENTS MUST BE 18 AND OLDER, MUST WEIGH AT LEAST 88 POUNDS. IT MUST OCCUR WITHIN 10POSSIBLE MUST UNDERLYING CONDITION. >> IF YOU HAVE CANCER. THOSE ARE EXAMPLES. >> WHAT ARE SOME OF THE SIDE EFFECTS INVOLVED WITH THIS TYPE OF TREATMENT? >> FEVER. BIT OF CHILLS. NAUSEA. >> THEIR PATIENTS HAVE NOT HAD ANY ADVERSE REACTIONS. SHE SAYS THE IMPACT OF THIS TREATMENT IS MULTIFACETED. >> THIS WILL DEFINITELY ALLEVIATE THE HEALTH CARE SYSTEM. IT WILL INCLUDING FAMILIES EMOTIONALLY AFFECTED BY COVID 19 DEATHS. >> KAY RECEDE. >> THE TREATMENT IS OFFERED FOR FREE FROM THE FEDERAL GOVERNMENT AND SENT DIRECTLY TO GOLDEN VALLEY. DOCTOR SORIANO SAYS ANYONE NEWLY DIAGNOSED WITH COVID-19 WHO FITS THE CRITERIA CAN CONTACT THE CL
Monoclonal antibody therapy shows promise among Modesto community clinic COVID-19 patients
A new treatment among COVID-19 positive patients at a Modesto area community health care clinic has shown promising results.The FDA approved monoclonal antibody therapy for emergency use in November. Golden Valley Health Centers began using the therapy the first week of February.Dr. Elaine Soriano said the treatment is a promising preventative measure that may reduce serious complications due to the virus.”(This is a) wonderful medication that is available to everyone, and we are happy at Golden Valley Health Centers to offer this medication for you if you have COVID and considered high risk,” Dr. Soriano told KCRA 3.Dr. Soriano added that GVHC is the only outpatient clinic in Modesto that currently offers the treatment used in this way.”Honestly, this is an underutilized medication that people may not know that it’s out there,” she said.She said, so far, patients have reacted well to the treatment, “and one of the patients that I talked to, he actually said could breathe better, his chest opened, up and he wanted to go out.”Dr. Soriano said there are some requirements.To receive treatment at GVHC, patients must be 18 or older, must weigh at least 88 pounds, the treatment must be used within the first 10 days of possible exposure, symptoms must be mild to moderate, and patients must have an underlying health condition, and if someone has an “immuno-compromised condition such as, you’re in chemotherapy, you have cancer, you have rheumatoid arthritis, lupus, those are just examples.”Dr. Soriano said in a clinical trial, side effects were similar to other infusion treatments, and occurred in less than 1% of users, “Low-grade fever, a little bit of chills, sometimes itchiness, nausea,” but she explained that none of their patients, so far, have had any adverse reactions. She also said, the potential impact of the treatment is multi-faceted.”This will definitely alleviate our healthcare system, this will definitely help everybody, including the families who are emotionally affected by the COVID-19 due to deaths of their families,” she said.The treatment is offered for free from the federal government and sent directly to Golden Valley Health Centers. Dr. Soriano encourages anyone who may have the criteria, to contact their health clinics.
A new treatment among COVID-19 positive patients at a Modesto area community health care clinic has shown promising results.
The FDA approved monoclonal antibody therapy for emergency use in November. Golden Valley Health Centers began using the therapy the first week of February.
Dr. Elaine Soriano said the treatment is a promising preventative measure that may reduce serious complications due to the virus.
“(This is a) wonderful medication that is available to everyone, and we are happy at Golden Valley Health Centers to offer this medication for you if you have COVID and considered high risk,” Dr. Soriano told KCRA 3.
Dr. Soriano added that GVHC is the only outpatient clinic in Modesto that currently offers the treatment used in this way.
“Honestly, this is an underutilized medication that people may not know that it’s out there,” she said.
She said, so far, patients have reacted well to the treatment, “and one of the patients that I talked to, he actually said could breathe better, his chest opened, up and he wanted to go out.”
Dr. Soriano said there are some requirements.
To receive treatment at GVHC, patients must be 18 or older, must weigh at least 88 pounds, the treatment must be used within the first 10 days of possible exposure, symptoms must be mild to moderate, and patients must have an underlying health condition, and if someone has an “immuno-compromised condition such as, you’re in chemotherapy, you have cancer, you have rheumatoid arthritis, lupus, those are just examples.”
Dr. Soriano said in a clinical trial, side effects were similar to other infusion treatments, and occurred in less than 1% of users, “Low-grade fever, a little bit of chills, sometimes itchiness, nausea,” but she explained that none of their patients, so far, have had any adverse reactions.
She also said, the potential impact of the treatment is multi-faceted.
“This will definitely alleviate our healthcare system, this will definitely help everybody, including the families who are emotionally affected by the COVID-19 due to deaths of their families,” she said.
The treatment is offered for free from the federal government and sent directly to Golden Valley Health Centers.
Dr. Soriano encourages anyone who may have the criteria, to contact their health clinics.